{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:11:30Z","timestamp":1789153890665,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>According to Chinese medicine, surgical trauma and chemotherapy aggravate patients\u2019 qi and blood deficiency and damage to the veins and channels. The combination of Chinese medicine and neoadjuvant chemotherapy (NACT) can not only improve the above symptoms, but also is expected to alleviate the adverse effects of breast cancer chemotherapy, such as nausea and vomiting, thereby improving patient compliance to achieve tumor reduction or even tumor-free, and providing a new diagnostic and therapeutic idea for the clinical treatment of breast cancer. This paper reported a case of human epidermal growth factor receptor 2 (HER-2) invasive breast cancer treated with traditional Chinese medicine combined with NACT. The lesion disappeared after 2 months of treatment and effectively reduced nausea and the symptoms of loss of appetite during NACT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient was a female, 54-year-old, unintentionally found a double breast lump with tingling pain over 1 year. During this period, the patient did not pay attention to any treatment, the mass increased progressively, hard texture, unclear boundary. Denied family genetic history of breast cancer. The patient was diagnosed with invasive ductal carcinoma of both breasts (multiple metastases in right axillary and supraclavicular lymph nodes), T4N3M0 (tumour staging basis), stage IIC, HER-2 positive by breast needle biopsy. In the course of NACT, the patient complained of severe nausea and vomiting, which seriously affected the quality of life and chemotherapy confidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was diagnosed with invasive ductal carcinoma of both breasts (multiple metastases in right axillary and supraclavicular lymph nodes), T4N3M0, stage IIC, HER-2 positive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with NACT, and traditional Chinese medicine was taken orally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After 2 months of combination therapy, the breast mass shrank, the symptoms of nausea and vomiting were significantly relieved, and the appetite became better. The biopsy of the breast tissue cut at the completion of NACT showed no upper, lower, internal, outer, and basal lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Chinese medicine internal effect is remarkable and safe, new adjuvant chemotherapy combined with Chinese medicine internal effectively improve nausea, vomiting symptoms, and effectively inhibit tumor hyperplasia, shrink tumor lesions, this case allows us consider whether in breast cancer new adjuvant chemotherapy combined Chinese medicine internal effect can be better, and provide new ideas for clinical treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043387","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:02:14Z","timestamp":1755543734000},"page":"e43387","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A case report of Chinese medicine combined with neoadjuvant chemotherapy in the treatment of human epidermal growth factor receptor 2 breast cancer"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1724-890X","authenticated-orcid":false,"given":"Shiyuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal and Breast Surgery, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Breast Surgery, Guizhou University of Traditional Chinese Medicine, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine of China, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"740427","DOI":"10.3389\/fonc.2021.740427","article-title":"TMB and TCR are correlated indicators predictive of the efficacy of neoadjuvant chemotherapy in breast cancer.","volume":"11","author":"Hongling","year":"2021","journal-title":"Front Oncol"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.annonc.2021.06.024","article-title":"Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.","volume":"32","author":"Miles","year":"2021","journal-title":"Ann Oncol"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"100512","DOI":"10.1016\/j.jcpo.2024.100512","article-title":"Health-related quality of life and associated factors in breast cancer patients in Abidjan (Ivory Coast).","volume":"42","author":"Odo","year":"2024","journal-title":"J Cancer Policy"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.breast.2021.07.019","article-title":"Dissecting the biological heterogeneity of HER2-positive breast cancer.","volume":"59","author":"Francesco","year":"2021","journal-title":"Breast"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000500298","article-title":"Long-term survival and cure in distant metastatic breast cancer.","volume":"97","author":"Uwe","year":"2019","journal-title":"Oncology (Huntingt)"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17410541.2024.2423601","article-title":"Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report.","volume":"21","author":"Kharel","year":"2024","journal-title":"Per Med"},{"key":"R7-20260911","first-page":"65","article-title":"Discussion on the treatment of breast cancer from the perspective of yin-yang deficiency theory.","volume":"29","author":"Du","year":"2022","journal-title":"MCM-TCM"},{"key":"R8-20260911","first-page":"745","article-title":"Study on the constitution types and syndrome distribution of TCM and their correlation in patients with breast cancer.","volume":"14","author":"Mo","year":"2019","journal-title":"WCM"},{"key":"R9-20260911","first-page":"5","article-title":"Expert consensus on internal treatment of TCM syndrome differentiation for early breast cancer.","volume":"27","author":"Chen","year":"2020","journal-title":"MCM-TCM"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","article-title":"Cancer-associated adipocytes: key players in breast cancer progression.","volume":"12","author":"Qi","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R11-20260911","first-page":"183","article-title":"The effect of Xiaoyao Loubei powder on peripheral blood T lymphocytes and drainage fluid inflammatory indicators in patients undergoing radical mastectomy for breast cancer.","volume":"42","author":"Zixuan","year":"2021","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"R12-20260911","first-page":"156","article-title":"Clinical observation on the treatment of postoperative upper limb lymphedema in breast cancer with Xiaoyao Lou Bei powder by syndrome differentiation.","volume":"39","author":"Chen","year":"2021","journal-title":"Sichuan J Tradit Chin Med"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"13197","DOI":"10.1073\/pnas.96.23.13197","article-title":"Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast.","volume":"96","author":"Jinno","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biopha.2018.09.038","article-title":"Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting \u03b2-catenin signaling.","volume":"108","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R15-20260911","first-page":"105","article-title":"Xiaoyao Lou Bei powder with modifications for intervention in patients with breast cancer during the perioperative period before surgery.","volume":"20","author":"Yiwei","year":"2019","journal-title":"J Shanxi Coll Tradit Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:01:58Z","timestamp":1789153318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":15,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043387","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"2025-02-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}